Cipla (CIPLA) — Corporate Governance

Cipla Limited entered into an exclusive 5-year supply and marketing agreement with Pfizer to distribute four brands: Corex (cough syrup), Dolonex (NSAID), Neksium (PPI), and Dalacin C (antibiotic) across India. Pfizer will continue manufacturing and supplying these medicines while Cipla handles marketing and distribution. No upfront consideration was exchanged. The partnership leverages Cipla's extensive distribution network to expand patient access to Pfizer's established portfolio.

📄 View Original Announcement (PDF)

📊 Stock Analysis — CIPLA ✨ Ask AI About This

About Cipla Limited (CIPLA)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,15,682.55 Cr P/E: 25.4 ROE: 14.6% ROCE: 19.4%

View full CIPLA stock details →

📡 Get AI alerts when CIPLA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track CIPLA — Free

💡 Ask AI about this filing

"How does this corporate governance affect Cipla Limited's outlook?" "What did Cipla Limited announce on 19 December 2025?" "Is this positive or negative for CIPLA?"

Ask AI Free →

📊 More CIPLA filings

See all CIPLA filings →

🔥 Also filed on 19 December 2025

RELIANCE Reliance Industries Limited Announcement ICICIBANK ICICI Bank Limited Offer Document TATAPOWER Tata Power Company Limited Corporate Action TATASTEEL Tata Steel Limited Announcement TATASTEEL Tata Steel Limited Announcement INFY Infosys Limited Corporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when CIPLA files new disclosures

Track CIPLA filings, board meetings, and corporate actions. Free email alerts at 5 PM.